Please login to the form below

Not currently logged in
Email:
Password:

EMA

This page shows the latest EMA news and features for those working in and with pharma, biotech and healthcare.

Future of MHRA uncertain amid Brexit-fuelled shake up

Future of MHRA uncertain amid Brexit-fuelled shake up

Trade unions and regulatory experts warn that budget and staff cuts may lead to drug approval delays or the UK regulator simply rubber-stamping EMA decisions. ... Given the important role played by the Medicines and Healthcare products Regulation Agency (

Latest news

More from news
Approximately 283 fully matching, plus 825 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 8 fully matching, plus 87 partially matching documents found.

Latest appointments

  • New hires at EMA, Gilead and BeiGene New hires at EMA, Gilead and BeiGene

    EMA gains a new executive director, Gilead appoints a new senior vice president and BeiGene hires a new chief business exec. ... European Medicines Agency (EMA). The European Medicines Agency (EMA) management board has nominated Emer Cooke (pictured above

  • New faces at Synergy Vision, Makara Health and JPA Health New faces at Synergy Vision, Makara Health and JPA Health

    regional health communications campaigns. In her new role, she will leverage her expertise in FDA/EMA communications, patient and physician education, scientific communications, issues management and celebrity engagement to serve JPA

  • NDA Group appoints Alison McGregor as its principal consultant NDA Group appoints Alison McGregor as its principal consultant

    Johan Stromquist, chief executive officer, NDA Group, said: “The US expansion is our main focus in 2018 and we are planning expanding our support for FDA and EMA submissions, milestone meetings

  • Dr Paula Salmikangas joins NDA Group Dr Paula Salmikangas joins NDA Group

    She is the former chair of the EMA’s Committee for Advanced Therapies and comes to NDA from the Finnish Medicines Agency, where she served as a research professor.

  • Dr Desiree Luthman joins Verona Pharma Dr Desiree Luthman joins Verona Pharma

    She has an accomplished track record of working closely with the FDA and EMA on behalf of international healthcare companies to achieve key regulatory milestones.

More from appointments
Approximately 14 fully matching, plus 18 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 21 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...